从质量升级到创新突围，悦康药业开启生物医药发展新范式

IT新闻网2025-05-04

在全球生物医药产业加速变革的当下，悦康药业集团股份有限公司凭借质量、创新与数字化三大核心驱动力，走出了一条差异化的高质量发展道路，成为行业转型升级的生动范本。质量始终是悦康药业发展的生命线。以盐酸二甲双胍缓释片为例，通过引入新型高端辅料革新生产工艺，在确保药效的同时，大幅缩小药品体积，降低原辅材料消耗，极大提升了患者用药的便利性。这一"工艺创新+质量升级"的模式，被成功复制到活心丸(浓缩丸)、...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2532931337?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-04 15:01","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2532931337","market":"sh","top_or_hot":-1,"title":"从质量升级到创新突围，悦康药业开启生物医药发展新范式","media":"IT新闻网","content":"<div>\n<p>在全球生物医药产业加速变革的当下，悦康药业集团股份有限公司凭借质量、创新与数字化三大核心驱动力，走出了一条差异化的高质量发展道路，成为行业转型升级的生动范本。质量始终是悦康药业发展的生命线。以盐酸二甲双胍缓释片为例，通过引入新型高端辅料革新生产工艺，在确保药效的同时，大幅缩小药品体积，降低原辅材料消耗，极大提升了患者用药的便利性。这一\"工艺创新+质量升级\"的模式，被成功复制到活心丸(浓缩丸)、...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050416001994ec0d9a&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>从质量升级到创新突围，悦康药业开启生物医药发展新范式</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n从质量升级到创新突围，悦康药业开启生物医药发展新范式\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-04 15:01 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050416001994ec0d9a&s=b><strong>IT新闻网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>在全球生物医药产业加速变革的当下，悦康药业集团股份有限公司凭借质量、创新与数字化三大核心驱动力，走出了一条差异化的高质量发展道路，成为行业转型升级的生动范本。质量始终是悦康药业发展的生命线。以盐酸二甲双胍缓释片为例，通过引入新型高端辅料革新生产工艺，在确保药效的同时，大幅缩小药品体积，降低原辅材料消耗，极大提升了患者用药的便利性。这一\"工艺创新+质量升级\"的模式，被成功复制到活心丸(浓缩丸)、...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050416001994ec0d9a&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"688658","symbol_name":"悦康药业","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050416001994ec0d9a&s=b","article_id":"2532931337","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050416001994ec0d9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2532931337","pubTimestamp":1746342064,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"质量始终是悦康药业发展的生命线。创新研发则为悦康药业开辟了全新增长曲线。目前，悦康药业在AI药物研发领域已斩获10余项授权专利，并在国际知名期刊发表2篇研究论文。从质量筑基到创新突破，再到数字赋能，悦康药业构建起\"质量打底、创新驱动、数字支撑\"的复合型发展体系。展望未来，凭借独特的竞争优势，悦康药业有望在全球生物医药市场中持续突破，为行业高质量发展注入新的活力。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"161726":"生物医药","399441":"生物医药","688658":"悦康药业","BK0239":"医药制造"},"translate_title":"From quality upgrade to innovation breakthrough, Yuekang Pharmaceutical opens a new paradigm of biomedical development","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"161726":1,"399441":1,"688658":1},"content_text":"在全球生物医药产业加速变革的当下，悦康药业集团股份有限公司凭借质量、创新与数字化三大核心驱动力，走出了一条差异化的高质量发展道路，成为行业转型升级的生动范本。质量始终是悦康药业发展的生命线。以盐酸二甲双胍缓释片为例，通过引入新型高端辅料革新生产工艺，在确保药效的同时，大幅缩小药品体积，降低原辅材料消耗，极大提升了患者用药的便利性。这一\"工艺创新+质量升级\"的模式，被成功复制到活心丸(浓缩丸)、奥美拉唑肠溶胶囊等核心产品上，形成了\"质量提升-市场拓展-研发迭代\"的良性循环，为企业转型发展积蓄了强大动能。创新研发则为悦康药业开辟了全新增长曲线。公司始终保持高强度研发投入，2024年研发投入达4.22亿元，占营业收入比重高达11.16%。凭借持续的创新投入，悦康药业收获丰硕成果：全年新增专利授权63项，累计专利数量达到317项。从打破国内ED治疗领域原研药空白的爱力士枸橼酸爱地那非，到引领中药现代化发展的注射用羟基红花黄色素A；从开创肝癌治疗新路径的反义核酸药物注射用CT102，到探索病毒防御新机制的多肽药物YKYY017，悦康药业的创新版图已覆盖中药创新药、核酸药物、多肽药物等多个前沿领域。在数字化浪潮中，悦康药业积极拥抱变革，与华为开展全面战略合作，加速推进数字化转型。公司全力打造全流程AI药物研发平台，将AI算法深度融入药物研发的各个环节，显著提升研发效率与成功率。目前，悦康药业在AI药物研发领域已斩获10余项授权专利，并在国际知名期刊发表2篇研究论文。由AI全程设计的创新药YKYY018更是备受行业关注，展现出强大的创新潜力。从质量筑基到创新突破，再到数字赋能，悦康药业构建起\"质量打底、创新驱动、数字支撑\"的复合型发展体系。这一成功经验为生物医药企业探索新质生产力提供了有益借鉴。展望未来，凭借独特的竞争优势，悦康药业有望在全球生物医药市场中持续突破，为行业高质量发展注入新的活力。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2532931337","isCrawlerRequest":true}